Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018

Overview

Journal Curr Hypertens Rev

Publisher Bentham Science Publishers

Specialty Cardiology & Vascular Diseases

Date 2019 Jan 19

PMID 30657043

Citations 46

Authors

Mehdi Jafari Oori

Farahnaz Mohammadi

Kian Norozi

Masoud Fallahi-Khoshknab

Abbas Ebadi

Reza Ghanei Gheshlagh

Affiliations

Soon will be listed here.

Abstract

Introduction: Prevalence of hypertension (HTN) is increasing in the developing countries like Iran. Various studies have reported different rates of HTN in Iran. The purpose of this study was to estimate an overall prevalence of HTN in Iran.

Methodology: Using the English and Persian key derived from Mesh, the databases including MagIran, Iran Medex, SID, Web of Sciences, PubMed, Science Direct and Google Scholar as a searching engine were reviewed: from 2004 to 2018. The overall prevalence of MA was estimated using Random effect model. The I2 test was used to assess the heterogeneity of the studies. Additionally, the quality of studies was evaluated using a standard tool. Publication bias was conducted with the Egger test. Meta-regression and analysis of subgroups were analyzed based on variables such as age, marital status, region and tools. Data were analyzed using STATA 12 software.

Results: Analysis of 58 primary articles with a sample size of 902580 showed that the prevalence of HTN in Iran was 25% (with 95% CI of 22-28). The highest prevalence of HTN was related to elderly (42%). The prevalence of HTN was 25% (95% CI: 19-31) in women and 24% (95% CI: 20-28) in men with no significant difference (p = 0.758). The results also indicated that the prevalence of HTN was not related to the year of studies (p = 0.708) or sample size (p = 769).

Conclusion: Despite the advancements in science and technology, along with health and prevention of diseases, the overall prevalence of HTN raised in Iran. Since HTN is a silent disease with significant health consequences and economic burden, programs designed to better HTN control seem vital to enhance community health.

Citing Articles

Does dietary intake of vitamin A and beta-carotene increase the risk of hypertension?.

Rahmanian S, Salimi Z, Masoumvand M, Aghakhani Nejad Z, Ghorbani Hesari M, Mirshafaei S Cardiovasc Endocrinol Metab. 2025; 13(4):e00316.

PMID: 40052141 PMC: 11884834. DOI: 10.1097/XCE.0000000000000316.

A Study on Prevalence and Factors Affecting Hypertension in an Iranian Population: Results from the Fasa Cohort Study.

Taheri Ghaleno S, Safari A, Homayounfar R, Farjam M, Rezaeian M, Asadi F Med J Islam Repub Iran. 2025; 38:123.

PMID: 39968471 PMC: 11835403. DOI: 10.47176/mjiri.38.123.

An Early View of Iran Primary Sjogren Syndrome Registry (Guilan Province Pilot Phase), an Emerging Effort for a National Registry Establishment.

Hajiabbasi A, Jamshidi A, Monfared A, Mohammadi M, Tangestani Nejad A, Shoaee S Med J Islam Repub Iran. 2025; 38:134.

PMID: 39968468 PMC: 11835400. DOI: 10.47176/mjiri.38.134.

The cost-effectiveness of peer education on medication adherence in the elderly with hypertension: a randomized controlled trial.

Ranjbar H, Sadeghi-Vazin K, Bakhshi M BMC Public Health. 2024; 24(1):3268.

PMID: 39587548 PMC: 11587726. DOI: 10.1186/s12889-024-20807-z.

Blood pressure status, quality of life, and emotional states in adults with different disease awareness and treatment adherence.

Niknam M, Zolfagharypoor A, Cheraghi L, Izadi N, Azizi F, Amiri P Sci Rep. 2024; 14(1):26699.

PMID: 39496726 PMC: 11535302. DOI: 10.1038/s41598-024-77857-x.

References

Haghdoost A, Sadeghirad B, Rezazadehkermani M . Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008; 11(4):444-52. DOI: 08114/AIM.0017. View

Sarki A, Nduka C, Stranges S, Kandala N, Uthman O . Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015; 94(50):e1959. PMC: 5058882. DOI: 10.1097/MD.0000000000001959. View

Ma W, Tang J, Zhang Y, Xu Y, Lin J, Li J . Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens. 2012; 25(5):590-6. DOI: 10.1038/ajh.2012.11. View

Cooper R, Amoah A, Mensah G . High blood pressure: the foundation for epidemic cardiovascular disease in African populations. Ethn Dis. 2003; 13(2 Suppl 2):S48-52. View

Basiratnia M, Derakhshan D, Ajdari S, Saki F . Prevalence of childhood obesity and hypertension in south of Iran. Iran J Kidney Dis. 2013; 7(4):282-9. View

Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M . Prevalence of Hypertension in Iran 1980-2012: A Systematic Review. J Tehran Heart Cent. 2017; 11(4):159-167. PMC: 5424849. View

Tsimicalis A, Stinson J, Stevens B . Quality of life of children following bone marrow transplantation: critical review of the research literature. Eur J Oncol Nurs. 2005; 9(3):218-38. DOI: 10.1016/j.ejon.2004.08.006. View

Addo J, Smeeth L, Leon D . Hypertension in sub-saharan Africa: a systematic review. Hypertension. 2007; 50(6):1012-8. DOI: 10.1161/HYPERTENSIONAHA.107.093336. View

Fryar C, Ostchega Y, Hales C, Zhang G, Kruszon-Moran D . Hypertension Prevalence and Control Among Adults: United States, 2015-2016. NCHS Data Brief. 2017; (289):1-8. View

10.

Rafraf M, Pourghassem Gargari B, Safaiyan A . Prevalence of prehypertension and hypertension among adolescent high school girls in Tabriz, Iran. Food Nutr Bull. 2010; 31(3):461-5. DOI: 10.1177/156482651003100308. View

11.

Ma Y, Mei W, Yin P, Yang X, Rastegar S, Yan J . Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS One. 2013; 8(3):e58302. PMC: 3590128. DOI: 10.1371/journal.pone.0058302. View

12.

Forouzanfar M, Liu P, Roth G, Ng M, Biryukov S, Marczak L . Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017; 317(2):165-182. DOI: 10.1001/jama.2016.19043. View

13.

Gheshlagh R, Sayehmiri K, Ebadi A, Dalvandi A, Dalvand S, Tabrizi K . Resilience of Patients With Chronic Physical Diseases: A Systematic Review and Meta-Analysis. Iran Red Crescent Med J. 2016; 18(7):e38562. PMC: 5027800. DOI: 10.5812/ircmj.38562. View

14.

Efstratopoulos A, Voyaki S, Baltas A, Vratsistas F, Kirlas D, Kontoyannis J . Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens. 2006; 19(1):53-60. DOI: 10.1016/j.amjhyper.2005.07.011. View

15.

Mahram M, Shahsavari D, Oveisi S, Jalilolghadr S . Comparison of hypertension and diabetes mellitus prevalence in areas with and without water arsenic contamination. J Res Med Sci. 2013; 18(5):408-12. PMC: 3810576. View

16.

Fezeu L, Kengne A, Balkau B, Awah P, Mbanya J . Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health. 2009; 64(4):360-5. PMC: 3094348. DOI: 10.1136/jech.2008.086355. View

17.

Sheeran P, Gollwitzer P, Bargh J . Nonconscious processes and health. Health Psychol. 2012; 32(5):460-73. DOI: 10.1037/a0029203. View

18.

Wysocki M, Luo X, Schmeidler J, Dahlman K, Lesser G, Grossman H . Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry. 2011; 20(2):179-87. PMC: 3225577. DOI: 10.1097/JGP.0b013e31820ee833. View

19.

Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F . Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res. 2010; 33(4):331-7. DOI: 10.1038/hr.2009.235. View

20.

Bello M . Nigerians wake up to high blood pressure. Bull World Health Organ. 2013; 91(4):242-3. PMC: 3629459. DOI: 10.2471/BLT.13.020413. View